Emergent BioSolutions Canada Inc. (formerly Adapt Pharma Canada Ltd.)
Registration:
12
of
13
(2023-12-01
to
2024-01-31)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
To increase access to publicly funded NARCAN®(Naloxone HCI) Nasal Spray.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|